Evidence map›Paper›PMID 31604922›Full record

ArticleNature communications2019

TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes.

Jason W Miklas, Elisa Clark, Shiri Levy, Damien Detraux, Andrea Leonard, Kevin Beussman, Megan R Showalter, Alec T Smith, Peter Hofsteen, Xiulan Yang and 11 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. HADHA Regulates Respiratory Complex Assembly and Couples FAO and OXPHOS.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  19. Review
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Jason W MiklasInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.
Elisa ClarkInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0003-4267-7215
Shiri LevyInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.
Damien DetrauxInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0002-9704-2076
Andrea LeonardInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.
Kevin BeussmanInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.
Megan R ShowalterNIH West Coast Metabolomics Center, University of California Davis, Davis, CA, 95616, USA.
Alec T SmithDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.
Peter HofsteenInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.
Xiulan YangInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.
Jesse MacadangdangInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.
Tuula ManninenHelsinki University Hospital, 00290, Helsinki, Finland.
Daniel RafteryDepartment of Anesthesiology and Pain Medicine, Mitochondria and Metabolism Center, University of Washington, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0003-2467-8118
Anup MadanCovance Genomics Laboratory, Redmond, WA, 98052, USA.
Anu SuomalainenHelsinki University Hospital, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0003-4833-5195
Deok-Ho KimInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0002-6989-6074
Charles E MurryInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0003-3862-6773
Oliver FiehnNIH West Coast Metabolomics Center, University of California Davis, Davis, CA, 95616, USA.ORCID http://orcid.org/0000-0002-6261-8928
Nathan J SniadeckiInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0001-6960-4492
Yuliang WangInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA.
Hannele Ruohola-BakerInstitute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, 98109, USA. hannele@u.washington.edu.
University of Washington · USUniversity of Helsinki · FICalifornia Institute for Regenerative Medicine · USCovance (United States) · USKing Abdulaziz University · SAUniversity of California, Davis · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Progenitor Cell Biology Consortium Administrative Coordinating CenterU01HL099997 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI TERRIN, MICHAEL L · 2009 to 2015
$29.9M
Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI MAUREEN E NEITZ · 1985 to 2026
$23.5M
Self Renewal and Differentiation of Human Embryonic Stem CellsP01GM081619 · NIGMS · UNIVERSITY OF WASHINGTON · PI MOON, RANDALL TODD · 2007 to 2017
$20.6M
Controlling Hematopoietic Lineage Commitment from ESC to PlateletsU01HL099993 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TOROK-STORB, BEVERLY J. · 2009 to 2015
$8.3M
Vector Research Resource CoreU54AR065139 · NIAMS · UNIVERSITY OF WASHINGTON · PI CHAMBERLAIN, JEFFREY S · 2014 to 2017
$6.3M
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHYR01HL146436 · NHLBI · UNIVERSITY OF WASHINGTON · PI KIM, DEOK-HO · 2019 to 2022
$2.2M
A NANOPATTERNED MEA-BASED FUNCTIONAL PHENOTYPING ASSAY FOR DRUG-INDUCED CARDIOTOXICITY SCREENINGR01HL135143 · NHLBI · UNIVERSITY OF WASHINGTON · PI KIM, DEOK-HO · 2017 to 2021
$1.9M
MicroRNA Function in Human Embryonic Stem CellsR01GM083867 · NIGMS · UNIVERSITY OF WASHINGTON · PI RUOHOLA-BAKER, HANNELE · 2008 to 2011
$1.5M
Acquisition of Embryonic Stem Cell Metabolic Signature - Minority SupplementR01GM097372 · NIGMS · UNIVERSITY OF WASHINGTON · PI RUOHOLA-BAKER, HANNELE · 2011 to 2014
$1.3M
Integrins, mechanotransduction, and the maturation of cardiomyocytes derived from induced pluripotent stem cellsF32HL126332 · NHLBI · UNIVERSITY OF WASHINGTON · PI LEONARD, ANDREA B · 2015 to 2017
$164k
NEI NIH HHS P30 EY001730NHLBI NIH HHS F32 HL126332NHLBI NIH HHS R01 HL135143NHLBI NIH HHS R01 HL146436NHLBI NIH HHS U01 HL099993NHLBI NIH HHS U01 HL099997NIAMS NIH HHS U54 AR065139NIDDK NIH HHS P30 DK017047NIGMS NIH HHS P01 GM081619NIGMS NIH HHS R01 GM083867NIGMS NIH HHS R01 GM097372
6 · The paper itself

Abstract

Mitochondrial trifunctional protein deficiency, due to mutations in hydratase subunit A (HADHA), results in sudden infant death syndrome with no cure. To reveal the disease etiology, we generated stem cell-derived cardiomyocytes from HADHA-deficient hiPSCs and accelerated their maturation via an engineered microRNA maturation cocktail that upregulated the epigenetic regulator, HOPX.  Here we report, matured HADHA mutant cardiomyocytes treated with an endogenous mixture of fatty acids manifest the disease phenotype: defective calcium dynamics and repolarization kinetics which results in a pro-arrhythmic state. Single cell RNA-seq reveals a cardiomyocyte developmental intermediate, based on metabolic gene expression. This intermediate gives rise to mature-like cardiomyocytes in control cells but, mutant cells transition to a pathological state with reduced fatty acid beta-oxidation, reduced mitochondrial proton gradient, disrupted cristae structure and defective cardiolipin remodeling. This study reveals that HADHA (tri-functional protein alpha), a monolysocardiolipin acyltransferase-like enzyme, is required for fatty acid beta-oxidation and cardiolipin remodeling, essential for functional mitochondria in human cardiomyocytes.

Indexed as

CalciumCardiolipinsCell LineElectrophysiologyFatty AcidsHomeodomain ProteinsHuman Embryonic Stem CellsHumansMicroRNAsMitochondriaMitochondrial Trifunctional ProteinMitochondrial Trifunctional Protein, alpha SubunitMyocytes, CardiacOxidation-ReductionPatch-Clamp TechniquesRNA-SeqCalciumCardiolipinsFatty AcidsHADHA protein, humanHomeodomain ProteinsHOPX protein, humanMicroRNAsMitochondrial Trifunctional ProteinMitochondrial Trifunctional Protein, alpha SubunitTumor Suppressor Proteins

Identifiers

PMID31604922
PMCPMC6789043
OpenAlexW2979529073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.